Orphan designation: Diacerein Treatment of epidermolysis bullosa, 20/02/2014 Positive
Retrieved on:
Thursday, April 18, 2024
Eurostat, Diagnosis, Civil service commission, Gene, Anthraquinones, Skin cancer, Epidermolysis bullosa, Disease, Inflammation, Patient, Committee, Knowledge, Regulation, Keratin, EMA, IRIS, Joint, Protein, Life expectancy, Deformity, Blister, Interleukin-1 family, Mouth, European, Skin, Collagen, COMP, Infection, Safety, European Commission, Pain, Osteoarthritis, Marketing, Swelling, FGK, Medicine, Pharmaceutical industry
Orphan designation: Diacerein Treatment of epidermolysis bullosa, 20/02/2014 Positive
Key Points:
Orphan designation: Diacerein Treatment of epidermolysis bullosa, 20/02/2014 Positive